Cord blood disorders is speculative, some research has been done in other areas. Any such potential beyond blood and immunological uses is limited by the fact that cord cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as embryonic stem cells, which can differentiate into any type of tissue). Cord blood has been studied as a treatment for diabetes. However, apart from blood disorders, the use of cord blood for other diseases is not in routine clinical use and remains a major challenge for the stem cell community. Along with cord blood, Wharton's
International Society of Blood Transfusion International Society of Blood Transfusion The International Society of Blood Transfusion (ISBT) is a scientific society, founded in 1935, which aims to promote the study of blood transfusion, and to spread the know-how about the manner in which blood transfusion medicine and science best can serve the patient's interests. The society's central office is in Amsterdam, and there are around 1700 members in 97 countries. Currently, the President is Martin L. Olsson. The Society organizes an international congress every other even year and two regional congresses in odd years, one in Europe and one in Asia. ISBT advocates standardisation and